Pharmacological Management of Obesity

Displaying 1 - 3 of 3CSV
Brezing, C. A., Sibai, M., Choi, C. J., Mitra, S., Mariani, J. J., Naqvi, N., Mahony, A. L., Brooks, D., Pavlicova, M., & Levin, F. R. (2023). Open-label pilot of lorcaserin (a serotonin 2C-receptor agonist) for cannabis use disorder. Journal of Substance Use, 29(4), 487–494. https://doi.org/10.1080/14659891.2023.2202760
Publication Date
Diamond, J. M., Benvenuto, L., Claridge, T., Witek, S., Christie, J. D., Singer, J. P., & Anderson, M. R. (2024). Provider beliefs and practices regarding the management of obesity in lung transplant recipients. JHLT Open, 3, 100028. https://doi.org/10.1016/j.jhlto.2023.100028
Publication Date
Lim, F., Bellows, B. K., Tan, S. X., Aziz, Z., Woo Baidal, J. A., Kelly, A. S., & Hur, C. (2023). Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents. JAMA Network Open, 6(8), e2329178. https://doi.org/10.1001/jamanetworkopen.2023.29178
Publication Date